TY  - JOUR
T1  - HOrmone therapy use and risk of ovarian cancer
AU  - MacLennan AH, Baber R
Y1  - 2009/11/25
N1  - 10.1001/jama.2009.1724
JO  - JAMA
SP  - 2203
EP  - 2204
VL  - 302
IS  - 20
N2  - 
The most common presentation of asymptomatic ovarian cancer is the chance finding of a pelvic mass at manual or ultrasonic pelvic examination.2 Women using HT are likely to present for routine pelvic examination more often than nonusers of HT. The potential for such detection bias was not discussed in the article but could account for the small annual increase in ovarian cancer incidence of 1 in 8300.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1724
UR  - http://dx.doi.org/10.1001/jama.2009.1724
ER  -